Neuroscience of Addiction and Mental Health Program, the Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
Clinical Psychopharmacology Unit (CPU), University College London, London, UK.
Addiction. 2022 Jun;117(6):1510-1517. doi: 10.1111/add.15702. Epub 2021 Oct 27.
The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use.
A group of 25 international expert cannabis researchers convened to discuss a multidisciplinary framework for minimum standards to measure cannabis use globally in diverse settings.
The expert-based consensus agreed upon a three-layered hierarchical framework. Each layer-universal measures, detailed self-report and biological measures-reflected different research priorities and minimum standards, costs and ease of implementation. Additional work is needed to develop valid and precise assessments.
Consistent use of the proposed framework across research, public health, clinical practice and medical settings would facilitate harmonisation of international evidence on cannabis consumption, related harms and approaches to their mitigation.
缺乏国际公认的衡量大麻使用的最低标准方法，阻碍了对大麻使用的社会心理、神经认知、临床和公共卫生后果的多学科证据的整合。
一组 25 名国际大麻研究专家召开会议，讨论一个多学科框架，以在不同环境下对全球大麻使用进行最低标准测量。
基于专家的共识达成了一个三层分层框架。每一层——通用措施、详细的自我报告和生物措施——反映了不同的研究重点和最低标准、成本和实施的难易程度。需要进一步的工作来开发有效和精确的评估方法。
在研究、公共卫生、临床实践和医疗环境中一致使用拟议框架，将有助于协调国际上关于大麻消费、相关危害和减轻危害方法的证据。
